EQUITY RESEARCH MEMO

Help Pharmaceuticals

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)60/100

Help Pharmaceuticals is a Greek pharmaceutical company founded in 1971, specializing in the development, manufacturing, and commercialization of high-quality pharmaceutical products. Operating as a contract development and manufacturing organization (CDMO) and generic drug supplier, the company offers a diverse portfolio including generics, OTCs, nutraceuticals, cosmeceuticals, and medical devices. With EU-GMP certified facilities, Help serves over 50 countries through flexible partnership models, leveraging its long-standing expertise and manufacturing capabilities to meet global demand. As a private company with a stable operational history, it continues to expand its reach in the generic and CDMO markets, positioning itself as a reliable partner in the pharmaceutical supply chain.

Upcoming Catalysts (preview)

  • Q4 2026New Generic Product Launches in European Markets70% success
  • Q2 2027Expansion of CDMO Contracts with International Partners65% success
  • TBDStrategic Partnership or Acquisition for Portfolio Diversification50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)